Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

NAV on March 28, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,104 cr
Turnover Ratio 28.44%
Expense Ratio 0.74%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: 7.90%
  • 1Y: 15.93%
  • 3M: -8.23%
  • 3Y: 20.73%
  • 6M: -8.11%
  • 5Y: 29.62%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Meeta Shetty (Since about 4 years) Rajat Srivastava (Since 7 months)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 31.87
P/B Ratio 4.70
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 3.08
Beta 0.95
R-Squared 96.77
Info Ratio 0.98
Tracking Err 3.11
Sortino 1.328
Sharpe 0.772
Std Dev 16.554
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 2.23%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 97.77%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
469.851 21.25% 3,313 cr 0.97% -
38.900 20.88% 4,611 cr 1.11% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata